Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma

被引：0
|
作者：
Kröger, N
Shimoni, A
Zagrivnaja, M
Ayuk, F
Lioznov, M
Schieder, H
Renges, H
Fehse, B
Zabelina, T
Nagler, A
Zander, A
机构：
[1] Zander Univ, Hosp Hamburg, Hamburg, Germany
[2] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
下载
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [1] Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma
    Kröger, N
    Shimoni, A
    Zagrivnaja, M
    Ayuk, F
    Lioznov, M
    Schieder, H
    Renges, H
    Fehse, B
    Zabelina, T
    Nagler, A
    Zander, AR
    BLOOD, 2004, 104 (10) : 3361 - 3363
  • [2] Low dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma.
    Kroeger, N
    Shimoni, A
    Zagrivnaja, M
    Ayuk, F
    Lioznov, M
    Schieder, H
    Fehse, B
    Zabelina, T
    Nagler, A
    Zander, A
    BLOOD, 2004, 104 (11) : 457A - 458A
  • [3] Adoptive immunotherapy with donor lymphocyte infusion after allogeneic nonmyeloablative stem cell transplantation.
    Qiao, ZH
    Zheng, ZZ
    Ye, F
    Ma, LM
    Gong, R
    BLOOD, 2005, 106 (11) : 383B - 383B
  • [4] Low-dose thalidomide (100 mg/die) followed by donor lymphocyte infusion in multiple myeloma patients with progressive disease or relapse after a tandem auto/allogeneic stem cell transplantation
    Martino, Massimo
    Console, Giuseppe
    Massara, Elisabetta
    Messina, Giuseppe
    Irrera, Giuseppe
    Stelitano, Caterina
    Callea, Vincenzo
    Kropp, Maria Grazia
    Piro, Eugenio
    Brugiatelli, Maura
    Molica, Stefano
    Iacopino, Pasquale
    ANNALS OF ONCOLOGY, 2007, 18 : 72 - 72
  • [5] Thalidomide and donor lymphocyte infusion in multiple myeloma patients with progressive disease or relapse after a tandem auto/allogeneic stem cell transplantation programme
    Martino, M.
    Console, G.
    Massara, E.
    Moscato, T.
    Messina, G.
    Fedele, R.
    Irrera, G.
    Iacopino, P.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S187 - S187
  • [6] Natural-killer cell (NK)-infusion as adoptive immunotherapy in patients with multiple myeloma relapsing after allogeneic stem cell transplantation
    Wolschke, C.
    Sputtek, A.
    Stuebig, T.
    Worthmann, F.
    van Randenborgh, A.
    Ayuk, F.
    Zander, A. R.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S198 - S198
  • [7] DONOR-LYMPHOCYTE INFUSION IN PATIENTS WITH PERSISTENT OR RECURRENT MULTIPLE MYELOMA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Beitinjaneh, A.
    Shah, N.
    Bashir, Q.
    Parmar, S.
    Hosing, C.
    Popat, U.
    Anderlini, P.
    Dinh, Y.
    Qureshi, S.
    Rondon, G.
    Champlin, R. E.
    Giralt, S.
    Qazilbash, M. H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S340 - S340
  • [8] Donor lymphocyte infusion after allogeneic stem cell transplantation
    Castagna, Luca
    Sarina, Barbara
    Bramanti, Stefania
    Perseghin, Paolo
    Mariotti, Jacopo
    Morabito, Lucio
    TRANSFUSION AND APHERESIS SCIENCE, 2016, 54 (03) : 345 - 355
  • [9] Low-dose preparative regimen and allogeneic stem cell transplantation in patients with multiple myeloma relapsing after autografting.
    Einsele, H
    Bamberg, M
    Schäfer, HJ
    Hebart, H
    Bader, P
    Budach, W
    Faul, C
    Brugger, W
    Kanz, L
    BLOOD, 1999, 94 (10) : 309B - 309B
  • [10] Adoptive immunotherapy with CD4+donor lymphocyte transfusions after allogeneic hematopoietic stem cell transplantation
    Wiesneth, M
    Stefanic, M
    Duncker, C
    von Harsdorf, S
    Krug, E
    Maccari, B
    Bunjes, D
    BONE MARROW TRANSPLANTATION, 1999, 23 : S4 - S4
12345